Vitalis Wellness & Medspa

Evolus Inc. is a performance beauty company focused on revolutionizing the aesthetics portfolio within the cash-pay market, emphasizing consumer value through innovative partnerships. Their flagship product, Jeuveau, is a proprietary neurotoxin designed to address moderate to severe frown lines and has been recognized as the fastest growing neurotoxin in the U.S. for four consecutive years.

In addition to Jeuveau, Evolus is set to launch Evolysse in 2025, a next-generation injectable hyaluronic acid technology crafted with Cold-X Technology that targets dynamic facial wrinkles. The company promotes enhanced patient experiences through the Evolus Rewards program, which encourages loyalty by offering consistent discounts to consumers seeking aesthetic treatments.

Generated from the website